OTCMKTS:ASCLF

Ascletis Pharma (ASCLF) Stock Price, News & Analysis

Ascletis Pharma logo
$0.63 0.00 (0.00%)
As of 11/13/2026

About Ascletis Pharma Stock (OTCMKTS:ASCLF)

Advanced

Key Stats

Today's Range
$0.63
▼
$0.63
50-Day Range
$0.63
▼
$1.30
52-Week Range
$0.62
▼
$2.50
Volume
N/A
Average Volume
2,773 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Ascletis Pharma Inc. is a China-based biopharmaceutical company focused on discovering, developing and commercializing innovative medicines. The company’s research and development activities have centered on viral diseases, liver diseases, oncology and metabolic disorders, with an emphasis on therapies addressing significant unmet medical needs.

Ascletis has developed and commercialized treatments for hepatitis C, including danoprevir, marketed in China under the brand name Ganovo. The company has also advanced additional antiviral programs and drug candidates targeting infectious diseases, while expanding its pipeline into areas such as cancer and metabolic disease.

Founded in 2014 and headquartered in Hangzhou, China, Ascletis operates primarily in the Chinese pharmaceutical market and has pursued international development and collaboration opportunities. The company was founded and is led by Dr. Jinzi J. Wang, who serves as chairman and chief executive officer.

AI Generated. May Contain Errors.

Receive ASCLF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ascletis Pharma and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ASCLF Stock News Headlines

Ascletis Pharma (OTCMKTS:ASCLF) Shares Down 13.2% - Should You Sell?
A $247 tool for $7
Bill Poulos is offering his $247 Instant Scanner for $7 in the Black Friday sale. It's one payment for a full year, with no re-bills and nothing to install. The catch? He isn't trying to profit on the scanner itself. Poulos is betting that once you see it deliver the night's list, you'll want more of his work for years.tc pixel
See More Headlines

ASCLF Stock Analysis - Frequently Asked Questions

Ascletis Pharma's stock was trading at $1.4850 at the beginning of 2026. Since then, ASCLF shares have decreased by 57.9% and is now trading at $0.6250.

Shares of ASCLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
OTCMKTS:ASCLF
CIK
N/A
Fax
N/A
Employees
202
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

This page (OTCMKTS:ASCLF) was last updated on 11/13/2026 by MarketBeat.com Staff.
From Our Partners